
Buy Adipotide Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy Adipotide Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA on Request
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA on Request
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
What is Adipotide?
Adipotide is a synthetic peptide with two joined parts: one that homes to the blood vessels feeding fat tissue, and one that triggers cell death in those vessel cells. It has been studied in animal research for its effects on fat tissue and body composition.
- A two-part peptide that homes to the blood supply of fat tissue and triggers cell death there
- Studied in animal research for its effects on fat tissue
- Works directly on fat-tissue blood vessels rather than through hormones or metabolism
- Primate studies looked at body-composition measures and fat-tissue volume
For research use only. Not approved for human therapeutic use.
Adipotide, also known as FTPP (Fat-Targeted Proapoptotic Peptide) and Prohibitin-TP01 (CAS 859216-15-2), is a synthetic peptidomimetic compound with a molecular weight of 2555.22 g/mol. Defined by the chimeric sequence CKGGRAKDC-GG-D(KLAKLAK)2, Adipotide consists of a nine-amino acid targeting motif (CKGGRAKDC) linked via a glycine-glycine spacer to a D-enantiomer proapoptotic peptide sequence. The targeting motif was identified through phage display screening and is associated with binding to prohibitin and annexin A2 (ANXA2). Produced via solid-phase peptide synthesis.
Adipotide has been studied for its chimeric design strategy, which couples a vascular targeting motif to a mitochondrial membrane-disrupting sequence. The CKGGRAKDC domain has been identified in phage display screens as binding to prohibitin and ANXA2, membrane proteins documented in published studies as expressed on the endothelial cells of white adipose tissue vasculature, a tissue-selective expression pattern that has been characterised as the molecular basis of the compound’s ligand-directed targeting approach in adipose vascular biology research. In vitro studies have examined the interaction between the CKGGRAKDC targeting motif and white adipose tissue vasculature-associated endothelial cell populations, documenting the phage display-identified peptide’s selective homing to WAT endothelium and characterising prohibitin and ANXA2 as the receptor basis of this endothelial cell targeting activity [1]. In vivo studies in rodent and non-human primate models have investigated body composition changes, white adipose tissue vascular dynamics, and the selectivity of the targeting domain for adipose-associated vasculature, with studies in obese rhesus macaques documenting that Adipotide administration induced targeted apoptosis within white adipose tissue vasculature and documented changes in body weight and insulin sensitivity parameters under controlled conditions [2], making Adipotide a reference compound in vascular-targeted peptidomimetic research across adipose tissue biology and ligand-directed apoptosis models.
Adipotide is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 14 June 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Select Size
Get notified when this batch is released
Enter your email and we'll let you know as soon as this product is available again.
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis and MSDS available on request.






